Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Enhancer RNA transcriptome-wide association study reveals an atlas of pan-cancer susceptibility eRNAs

Wenyan Chen, Zeyang Wang, Jianxiang Lin, Shuxin Chen, Hui Chen, Xuelian Ma, Xudong Zou, Xing Li, Yinuo Wang, Yangmei Qin, Xixian Ma, Yunbo Qiao, Lei Li
doi: https://doi.org/10.1101/2024.02.29.24303580
Wenyan Chen
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeyang Wang
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianxiang Lin
2Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200125, China
3Shanghai Institute of Precision Medicine, 200125, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuxin Chen
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Chen
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuelian Ma
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xudong Zou
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xing Li
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yinuo Wang
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yangmei Qin
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xixian Ma
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunbo Qiao
2Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200125, China
3Shanghai Institute of Precision Medicine, 200125, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lei.li{at}szbl.ac.cn ybqiao{at}shsmu.edu.cn
Lei Li
1Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen 518055, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lei.li{at}szbl.ac.cn ybqiao{at}shsmu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Many cancer risk variants are located within enhancer regions and lack sufficient molecular interpretation. Here, we constructed the first comprehensive atlas of enhancer RNA (eRNA)- mediated genetic effects from 28,033 RNA sequencing samples across 11,606 individuals, identifying 11,757 eRNA quantitative trait loci (eRNA-QTLs) significantly associated with eRNA expression. Mechanistically, eRNA-QTLs frequently altered binding motifs of transcription factors. In addition, 28.48% of cancer risk variants were strongly colocalized with eRNA-QTLs. We further performed an eRNA-based transcriptome-wide association study and identified 626 cancer susceptibility eRNAs across 23 cancer types. 54.9% of the eRNA target genes were overlooked by traditional gene expression studies, and most are essential for cancer cell proliferation. To substantiate our findings, we confirmed the enhancer functionality of two newly identified susceptibility eRNAs, CCND1e and SNAPC1e, through CRISPR-based inhibition, resulting in a marked decrease in the expression of their respective target genes, consequently suppressing the proliferation of prostate cancer cells. Our study underscores the essential role of eRNA in unveiling new cancer susceptibility genes and establishes a strong framework for enhancing our understanding of human cancer etiology.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Natural Science Foundation of China [no. 32100533 to LL] and Open grant funds from Shenzhen Bay Laboratory [no. SZBL2021080601001 to L.L.].

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The data presented in this study can be freely accessed, queried, visualized, and downloaded through the dedicated eRNA-QTL website portal at http://bioinfo.szbl.ac.cn/eRNA-QTL-atlas/. Sequencing data are deposited in the Gene Expression Omnibus (GEO) database (accession number: GSE242322).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 02, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Enhancer RNA transcriptome-wide association study reveals an atlas of pan-cancer susceptibility eRNAs
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Enhancer RNA transcriptome-wide association study reveals an atlas of pan-cancer susceptibility eRNAs
Wenyan Chen, Zeyang Wang, Jianxiang Lin, Shuxin Chen, Hui Chen, Xuelian Ma, Xudong Zou, Xing Li, Yinuo Wang, Yangmei Qin, Xixian Ma, Yunbo Qiao, Lei Li
medRxiv 2024.02.29.24303580; doi: https://doi.org/10.1101/2024.02.29.24303580
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Enhancer RNA transcriptome-wide association study reveals an atlas of pan-cancer susceptibility eRNAs
Wenyan Chen, Zeyang Wang, Jianxiang Lin, Shuxin Chen, Hui Chen, Xuelian Ma, Xudong Zou, Xing Li, Yinuo Wang, Yangmei Qin, Xixian Ma, Yunbo Qiao, Lei Li
medRxiv 2024.02.29.24303580; doi: https://doi.org/10.1101/2024.02.29.24303580

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)